HOOKIPA Pharma Inc.
Daniela Skodackova has a diverse work experience spanning different roles and industries. Daniela started their career as a French language teacher at TelMi in 2012. In 2016, they worked as a pharmacist at Centre Hospitalier Universitaire Saint-Pierre Bruxelles for a short period of time. From 2017 to 2019, they worked as a Technology Specialist in the R&D department at Saneca Pharma. Daniela then moved on to HOOKIPA Pharma Inc., where they held various positions including Junior Manager - External Manufacturing, Manager - External Manufacturing, Head of External Manufacturing, and currently serves as the Director of Drug Supply & External Partnerships.
Daniela Skodackova holds a Master's degree in Pharmacy from Univerzita Komenského v Bratislave, which they obtained from 2012 to 2017. Daniela also completed their Erasmus studies in Pharmacy at the University of Eastern Finland from 2014 to 2015. Prior to that, from 2003 to 2011, they pursued bilingual studies in French at Gymnázium Ľudovíta Štúra, Trenčín.
This person is not in the org chart
This person is not in any offices
HOOKIPA Pharma Inc.
At HOOKIPA, we envision a world in which cancers and infectious diseases can be chronically managed or eradicated. HOOKIPA Pharma Inc. (NASDAQ: HOOK) is a clinical-stage biopharmaceutical company advancing the field of immunotherapy through the development of new immunotherapies based on our proprietary arenavirus platform, which is designed to mobilize and amplify targeted T cells and thereby fight or prevent serious disease. Our pipeline includes wholly owned investigational arenaviral immunotherapies targeting HPV16+ cancers, prostate cancer, KRAS-mutated cancers (including colorectal, pancreatic and lung), and other undisclosed programs. In addition, HOOKIPA aims to develop functional cures for HBV and HIV in collaboration with Gilead. As a company, we fight for innovation; we challenge ourselves to act authentically and transparently; we thrive on our differences; and we go for it, never giving up in our efforts to eliminate the suffering of people with cancer and infectious disease. To learn more please visit www.hookipapharma.com.